BACKGROUND
Uncontrolled bleeding is an important cause of increased transfusion in burn victims; however, description of blood utilization patterns in the burn population is lacking.
STUDY DESIGN AND METHODS
We conducted a single-institution, retrospective cohort study to measure blood utilization in 89 consecutive burn patients with 15–65% total body surface area (TBSA) burn within 60 days of injury. We also evaluated the relationship of blood product utilization with clinical variables including anticoagulant usage and mortality.
RESULTS
We determined that: (a) the predictors for increased packed red blood cells (PRBC) and plasma transfusions were high TBSA burn and the use of argatroban anticoagulation (for suspected heparin-induced thrombocytopenia); (b) TBSA burn and patient age were independent predictors of mortality, but not PRBC or plasma transfusion; and (c) the incidence of symptomatic venous thromboembolic events is not uncommon (11.2%), although heparin-induced thrombocytopenia is rare (1.1%).
CONCLUSION
Despite concerns about adverse correlation between increased number of transfusions and mortality in other clinical settings, we did not find this association in our study. However, we demonstrated that the type and intensity of anticoagulation carries substantial risk for increased PRBC as well as plasma usage.